Published in Blood Weekly, September 28th, 2000
This is according to a multicenter study presented at the inaugural Congress of the International Pediatric Transplant Association (IPTA), held in Venice, Italy, during September 2000.
"Because of the unique challenges we face in treating children, we are always excited to find well tolerated therapeutic agents and combinations," said Jacques Lamire, MD, University of California, San Diego Medical Center. "This study shows that the combination therapy of Simulect...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.